Counterpoint Mutual Funds’s MaxLinear MXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-62,530
Closed -$679K 395
2025
Q1
$679K Buy
62,530
+33,709
+117% +$564K 0.1% 122
2024
Q4
$570K Buy
28,821
+8,920
+45% +$143K 0.07% 111
2024
Q3
$288K Buy
+19,901
New +$316K 0.05% 133
2024
Q2
Sell
-15,755
Closed -$294K 270
2024
Q1
$294K Buy
+15,755
New +$315K 0.07% 69
2023
Q4
Sell
-5,943
Closed -$132K 224
2023
Q3
$132K Buy
+5,943
New +$151K 0.11% 108

Other funds holding MXL

Counterpoint Mutual Funds's MXL Position: Q2 2025 in Review

Counterpoint Mutual Funds sold out of MaxLinear (MXL) in Q2 2025, closing a stake of 62,530 shares — an estimated $679K sold.

Counterpoint Mutual Funds first reported a position in MXL in Q3 2023 and held it in 5 quarters. The position peaked at $679K in Q1 2025. 218 funds tracked by Wall St. Rank hold MXL as of Q2 2025.

  • Counterpoint Mutual Funds reported no remaining MaxLinear position as of Q2 2025 after selling out during the quarter.
  • Counterpoint Mutual Funds sold 62,530 MaxLinear shares in Q2 2025, an estimated $679K.
  • Counterpoint Mutual Funds first reported a position in MaxLinear in Q3 2023 and held it in 5 quarters.
  • Counterpoint Mutual Funds's MaxLinear position peaked at $679K in Q1 2025.
  • 218 funds tracked by Wall St. Rank held MaxLinear as of Q2 2025.

Based on Counterpoint Mutual Funds's 13F filing for Q2 2025, filed 14 Jul 2025.